This topic contains a solution. Click here to go to the answer

Author Question: In controlling internal sources of invalidity, true experimental designs control for a. all of the ... (Read 58 times)

a0266361136

  • Hero Member
  • *****
  • Posts: 538
In controlling internal sources of invalidity, true experimental designs control for
 a. all of the sources of internal invalidity
  b. all of the sources of internal invalidity except selection bias and test unit mortality
  c. selection bias, instrumentation, and interactive testing effects only
  d. selection bias and test unit mortality only

Question 2

Find the median of the following scores: 1, 2, 3, 4, 5, 5, 7
 a. 3.86
  b. 4
  c. 6
  d. 27



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Christopher

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

A
One of the primary advantages of true experimental designs is they control for all of the internal sources of invalidity.

Answer to Question 2

B




a0266361136

  • Member
  • Posts: 538
Reply 2 on: Jun 29, 2018
Wow, this really help


cassie_ragen

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

For a complete list of videos, visit our video library